Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction

American Journal of Cardiology

Volumn 79, Issue 5, 1997, Pages 590-594

  Talley, J David ^a   Ohman, E Magnus ^b   Mark, Daniel B ^b   George, Barry S ^b   Leimberger, Jeffrey D ^b   Berdan, Lisa G ^b   Davidson Ray, Linda ^b   Rawert, Millie ^b   Lam, Lai Choi ^b   Phillips, Harry R ^b   Califf, Robert M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; AORTA BALLOON; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUNTERPULSATION; ECONOMIC ASPECT; FEMALE; HEART CATHETERIZATION; HOSPITAL COST; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 8244223876     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(96)00821-1     Document Type: Article

References (8)

1. Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ, Harrelson-Woodlief L, Candela RJ, Flanagan C, Stack RS, Topol EJ, and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991;121:895-901.
2. Ishihara M, Sato H, Tateishi H, Uchida T, Dote K. Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction. Am Heart J 1991;122:385-389.
3. Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, Lundergan C, Hartmann JR, Talley JD, Frey MJ, for the Randomized IABP Study Group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. Circulation 1994;90:792-799.
4. Griffin J, Grines, CL, Marsalese D, Spain M, Brodie B, Donohue B, Wharton T Jr, Stone GW, Balestrini C, Costantini C, Shimshak R, Delcan JL, Jones D, Mason D, Sachs D, O'Neill WW. A prospective, randomized trial evaluating the prophylactic use of balloon pumping in high-risk myocardial infarction patients: PAMI-2 (abstr). J Am Coll Cardiol 1995;25:86A.
5. Talley JD. News and views: progress in interventional cardiology. J Intervent Cardiol 1995;8:438-441.
6. Mark DB. Medical economics and health policy issues for interventional cardiology. In: Topol EJ, ed. Textbook of Interventional Cardiology. 2nd ed. Philadelphia: W.B. Saunders; 1994;1323-1353.
7. Barbagelata A, Granger CB, Topol EJ, Worley SJ, Kereiakes DJ, George BS, Ohman EM, Leimberger JD, Mark DB, Califf RM, for the TAMI Study Group. Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1995;76:1007-1013.
8. Ohman EM, George BS, White CJ, Kern MJ, Freedman RJ, Hartmann JR, Leimberger JD, Berdan LG, Stack RS, for the Randomized IABP Study Group. Long-term follow-up after aortic counterpulsation insertion in acute myocardial infarction: results from a randomized clinical trial (abstr). Circulation 1994;90:1-169.